Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oxprenolol in clinical practice.

S H Taylor

    The American Journal of Cardiology
    |November 10, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Oxprenolol, a noncardioselective beta-blocker with partial agonist activity, effectively treats cardiovascular conditions like angina and hypertension. It demonstrates high tolerability and offers benefits in both primary and secondary cardiovascular disease prevention.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Maximal stomatal conductance to water and plasticity in stomatal traits differ between native and invasive introduced lineages of Phragmites australis in North America.

    AoB PLANTS·2016
    Same author

    Photosynthetic pathway and ecological adaptation explain stomatal trait diversity amongst grasses.

    The New phytologist·2011
    Same author

    Drought limitation of photosynthesis differs between C₃and C₄grass species in a comparative experiment.

    Plant, cell & environment·2010
    Same author

    Effects of chronic hepatitis C infection on the treatment of breast cancer patients.

    Annals of oncology : official journal of the European Society for Medical Oncology·2009
    Same author

    Efficacy and tolerability of amlodipine in the general practice treatment of essential hypertension in an asian multinational population.

    Clinical drug investigation·2008
    Same author

    Social work practice with people with disabilities in the era of disability rights.

    Social work in health care·2001
    Same journal

    Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

    The American journal of cardiology·2026
    Same journal

    ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

    The American journal of cardiology·2026
    Same journal

    Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

    The American journal of cardiology·2026
    Same journal

    Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

    The American journal of cardiology·2026
    Same journal

    Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

    The American journal of cardiology·2026
    Same journal

    Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

    The American journal of cardiology·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiology
    • Internal Medicine

    Background:

    • Oxprenolol is a noncardioselective beta-adrenoceptor blocking drug.
    • It possesses partial agonist activity, contributing to its efficacy and tolerability.
    • The drug is indicated for patients at risk of various cardiovascular disease syndromes.

    Purpose of the Study:

    • To evaluate the efficacy and tolerability of oxprenolol in managing cardiovascular conditions.
    • To assess its role in angina relief, blood pressure reduction, and prevention of cardiovascular events.
    • To highlight its benefits in mitigating the effects of stress, anxiety, and smoking on cardiovascular health.

    Main Methods:

    • Clinical assessment of oxprenolol's effects on angina and myocardial ischemia.

    Related Experiment Videos

  • Evaluation of its antihypertensive properties at rest and during stress.
  • Analysis of its impact on somatic sequelae of psychic stress and anxiety.
  • Investigation of its effects on cardiovascular and metabolic responses to cigarette smoking.
  • Review of its role in primary and secondary cardiovascular disease prevention, including post-myocardial infarction outcomes.

    • Main Results:

    • Oxprenolol rapidly relieves angina and reduces electrocardiographic evidence of myocardial ischemia.
    • It effectively lowers blood pressure at rest and prevents exercise- and stress-induced surges.
    • The drug alleviates somatic symptoms associated with psychic stress and anxiety.
    • It suppresses cardiovascular and metabolic effects of cigarette smoking.
    • Oxprenolol shows potential in reducing long-term cardiovascular complications of hypertension and decreasing sudden death incidence post-myocardial infarction.

    Conclusions:

    • Oxprenolol is a well-tolerated and effective drug for managing cardiovascular diseases.
    • Its partial agonist activity contributes to its favorable risk-benefit profile.
    • Established clinical use over 15 years confirms its high tolerability and therapeutic value in diverse cardiovascular applications.